Financials, Automotive, Technology Nov 29, 2021 05:19 PM (GMT+8) · EqualOcean
Financial Associated Press, Nov. 29 - Haili biology announced that the company's controlling subsidiary Yangling Jinhai Biotechnology Co., Ltd. ("Yangling Jinhai") borrowed a total of 404.8 million from the controlling shareholder Shanghai Haoyuan Venture Capital Development Co., Ltd. (formerly Shanghai Haoyuan Technology Development Co., Ltd., "Shanghai Haoyuan") and extended it to December 31, 2022. At the same time, it was announced that the total amount of idle self owned funds to be used should not exceed 500 million yuan.
Related companies: